Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Plasmablastic Lymphoma 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Hodgkin Disease 1HIV Infections 1Glioma 1Glioblastoma 1Burkitt Lymphoma 1Astrocytoma 1

Interventions

Temozolomide 15Radiotherapy 12Lomustine 5Carboplatin 5Vincristine 4Carmustine 4Granulocyte Colony-Stimulating Factor 3Filgrastim 3Etoposide 3Chemotherapy, Adjuvant 3lonafarnib 2imetelstat 2etoposide phosphate 2Thiotepa 2Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Radiation 2Psychiatric Rehabilitation 2Procarbazine 2Peripheral Blood Stem Cell Transplantation 2Magnetic Resonance Spectroscopy 2Irinotecan 2Drug Therapy 2vorasidenib 1veliparib 1transforming growth factor(alpha)-Pseudomonas aeruginosa exotoxin (38) 1selinexor 1sargramostim 1palbociclib 1laromustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Astrocytoma × carmustine, poliferprosan 20 drug combination × Clear all
NCT03722355 2019-11-12

Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma

Radiation Therapy Oncology Group

Phase 3 Completed
712 enrolled
CNS

Astrocytoma, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡